159 related articles for article (PubMed ID: 8452316)
1. IgE response in multiple myeloma.
Tamir R; Barchat I; Weiss H; Pick AI
Ann Allergy; 1993 Mar; 70(3):214-7. PubMed ID: 8452316
[TBL] [Abstract][Full Text] [Related]
2. Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myeloma.
Matta GM; Battaglio S; Dibello C; Napoli P; Baldi C; Ciccone G; Coscia M; Boccadoro M; Massaia M
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5348-54. PubMed ID: 17875762
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein.
Anagnostopoulos A; Galani E; Gika D; Sotou D; Evangelopoulou A; Dimopoulos MA
Ann Hematol; 2004 Oct; 83(10):658-60. PubMed ID: 15278296
[TBL] [Abstract][Full Text] [Related]
4. Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma.
Hayes MJ; Carey JL; Krauss JC; Hedstrom DL; Gulbranson RL; Keren DF
Eur J Haematol; 2007 Apr; 78(4):353-7. PubMed ID: 17378894
[TBL] [Abstract][Full Text] [Related]
5. Suppression of polyclonal immunoglobulin production by M-proteins shows isotype specificity.
Wang L; Young DC
Ann Clin Lab Sci; 2001 Jul; 31(3):274-8. PubMed ID: 11508831
[TBL] [Abstract][Full Text] [Related]
6. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
Chiu W; Pullon H; Woon ST; Oei P; The R; Ameratunga R
Pathology; 2010 Jan; 42(1):82-4. PubMed ID: 20025486
[No Abstract] [Full Text] [Related]
7. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
[TBL] [Abstract][Full Text] [Related]
8. Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy.
Niermeijer JM; Eurelings M; Lokhorst H; Franssen H; Fijnheer R; Wokke JH; Notermans NC
Neurology; 2006 Dec; 67(11):2076-9. PubMed ID: 17159126
[TBL] [Abstract][Full Text] [Related]
9. Serum IgE levels and reaginic-type skin reactions in sarcoidosis.
Yagura T; Shimizu M; Yamamura Y; Tachibana T
Clin Exp Immunol; 1975 Aug; 21(2):289-97. PubMed ID: 810284
[TBL] [Abstract][Full Text] [Related]
10. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
[TBL] [Abstract][Full Text] [Related]
11. Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation.
Hovenga S; de Wolf JT; Guikema JE; Klip H; Smit JW; Smit Sibinga CT; Bos NA; Vellenga E
Bone Marrow Transplant; 2000 Apr; 25(7):723-8. PubMed ID: 10745257
[TBL] [Abstract][Full Text] [Related]
12. [Multiple myeloma (IgG-kappa) infiltrating central nervous system, lymph nodes, liver, and kidneys, and with elevation of IgE].
Toyota S; Nakamura N; Dan K
Rinsho Ketsueki; 2004 May; 45(5):408-10. PubMed ID: 15199753
[TBL] [Abstract][Full Text] [Related]
13. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
[TBL] [Abstract][Full Text] [Related]
14. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
Fisher MA; Wilson JR
Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821
[TBL] [Abstract][Full Text] [Related]
15. [Clinical value of the blood measurement of the free light chains of immunoglobulins].
Bidet A; Marit G; Bérard AM
Ann Biol Clin (Paris); 2008; 66(4):427-31. PubMed ID: 18725344
[TBL] [Abstract][Full Text] [Related]
16. Biclonal gammopathy in multiple myeloma: a case report.
Bakta IM; Sutarka IN
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
[TBL] [Abstract][Full Text] [Related]
17. CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q.
Liebisch P; Eppinger S; Schöpflin C; Stehle G; Munzert G; Döhner H; Schmid M
Haematologica; 2005 Apr; 90(4):489-93. PubMed ID: 15820944
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.
Kumar S; Rajkumar SV; Kyle RA; Lacy MQ; Dispenzieri A; Fonseca R; Lust JA; Gertz MA; Greipp PR; Witzig TE
J Clin Oncol; 2005 Aug; 23(24):5668-74. PubMed ID: 16110026
[TBL] [Abstract][Full Text] [Related]
19. Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance.
Rossi F; Petrucci MT; Guffanti A; Marcheselli L; Rossi D; Callea V; Vincenzo F; De Muro M; Baraldi A; Villani O; Musto P; Bacigalupo A; Gaidano G; Avvisati G; Goldaniga M; Depaoli L; Baldini L
Clin Cancer Res; 2009 Jul; 15(13):4439-45. PubMed ID: 19509142
[TBL] [Abstract][Full Text] [Related]
20. B and T lymphocytic populations and subpopulations and natural killer cells (NK) in blood of patients with myeloma and with monoclonal gammopathy of undetermined significance (MGUS).
Büchi G; Girotto M; Termine G; Gario S; Grosso E; Autino R; Zappalà C
Pathologica; 1985; 77(1050):385-93. PubMed ID: 3879633
[No Abstract] [Full Text] [Related]
[Next] [New Search]